The Efficient Way to Invest in Cryptocurrency

Woodland Hills, CA, July 13, 2022 – BMCS Sumcoin Index Fund (formerly Bio Tech Medics name change is in process) stock Symbol BMCS-OTC, today announced their sponsorship of racing professionals and brothers Michael and Nicholas d’Orlando in the 2022 Honda Indy Toronto, Canada scheduled July 15-17, 2022. The brothers compete in the Road to Indy presented by Cooper Tires Ladder Series. Cars racing at this event will have BMCS and Sumcoin logos affixed to the vehicles. Investors and interested parties wanting to view this televised event on Peacock (which boast of 28 million monthly subscribers), can check out this link for more details about this event… https://www.indycar.com/Schedule/2022/IndyCar-Series/Toronto  and https://www.usf2000.com/results/live-timing

According to Anthony K. Miller, CEO This is a tremendous relationship that is targeted to bring awareness to BMCS and Sumcoin; and this high-profile event will be a significant game changer for our ventures. The BMCS Sumcoin Index Fund project is an efficient alternative method for investing in cryptocurrency (see below). The entire crypto landscape is still burgeoning even with the ups and downs that our industry has been facing and note the digital marketplace is resilient and is here to stay.

It is Management’s belief that Sumcoin is an overlooked digital asset and our 3 goals with this venture are to enhance the value and liquidity of Sumcoin in the digital ecosystem, to increase the BMCS share value and introduce investors to our Reg. D. 506c stock offering. “We are so proud of this relationship with the brothers Michael and Nicholas d’Orlando. “Sponsoring the d’Orlando brothers is an important step towards getting the awareness for all of our assets.” commented Miller

About DELLC (http://www.dorlandoracing.com/)

DELLC is the home of two of North America’s top drivers in driver development programs and United States open wheel racing series. Located in Hartsdale, New York, competing with powerhouse teams throughout North America, both d’Orlando pilots have extensive resumes to their credit with over a decade of racing experience starting in go-karting and now in the Road to Indy presented by Cooper Tires Ladder Series.

About BMCS Sumcoin Index Fund (https://bmcssumcoin.com/)

BMCS SUMCOIN INDEX FUND is a Delaware statutory trust that holds Sumcoin on behalf of its shareholders. The fund seeks to track the top 100 crypto currencies (digital assets) in the ecosystem “the Sumcoin value” and the trustee serves as custodian of the fund’s Sumcoin. It is open for eligible individual and institutional accredited investors with $25,000 or more to invest in Sumcoin. BMCS is actively moving to be elevated to the next tier on OTC markets OTCQB and to obtain all regulatory compliances. The BMCS Sumcoin Index Fund, Inc. name will be effective upon FINRA very approval. Investors who invest in our stock offering don’t have to do fancy research in the crypto marketplace… Sumcoin is a crypto alternative, offering for investors who want to invest in cryptocurrencies but may only want to hold one coin for simplicity.

READ MORE ABOUT SUMCOIN: https://www.sumcoin.org/

Forward-Looking Statements: This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including those with respect to the expected projects of BioTech Medics, Inc., and related companies. All statements that are included in this Press release, other than statements of historical fact, are forward-looking statements. Forward-looking statements involve known and unknown risks, assumptions, uncertainties, and other factors. Statements made in the future tense, and statements using-words-such as “may, “can,” “could,” “should,” “predict,” “aim'” “potential,” “continue,” “opportunity,” “intend ” “goal,” “estimate,”

“expect,” “expectations,” “project,” “projections,” “plans,” “anticipates,” “believe,” “think,” “confident” “scheduled” or similar expressions are intended to identify forward-looking statements. Forward-looking statements are not a guarantee of performance and are subject to a number of risks and uncertainties, many of which are difficult to predict and are beyond our control.

These risks and uncertainties could cause actual results to differ materially from those expressed in or implied by the forward-looking statements, and therefore should be carefully considered. You should consider the areas of risk described in connection with any forward-looking statements that may be made herein. We caution you not to place undue reliance on the forward-looking statements, which speak only as of the date of this report and readers should carefully review this report in its entirety. We disclaim any obligation to update any of these forward-looking statements as a result of new information, future events, or otherwise, except as expressly required by law. Further information on our risk factors is contained in our filings with the OTC Markets and the SEC website. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.